큐렉소

060280KOSDAQ

45.3 / 100

Reference Date: 2026-09-08

Financial Score11.0 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 7.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Quelex operates in three business segments: medical robotics, implants, and trade. It sells surgical robots such as 'Cuvis-Joint' and 'Cuvis-Spine' for orthopedic and spinal surgery, as well as a rehabilitation robot called 'Morning Walk'. The medical robotics market is growing rapidly due to increased demand for minimally invasive surgery, with the spinal surgery robot market projected to reach $2.77 billion by 2022.

Number of Employees

103people

Average Salary

62.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

121.34Industry Average 15.000.0Point

8.1x industry avg (risky)

PBR

3.49Industry Average 1.200.0Point

2.9x industry avg (risky)

ROE

2.92Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

0.70Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.2% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼236.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.8% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
알테오젠 하반기 기술수출 계약 체결 임박…‘RNA·인비보 CAR-T' ...
큐렉소 관련 알테오젠의 RNA 기술 수출 계약 체결 소식으로 긍정적 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 8,130Won52-week high 20,35052-week low 7,260

1-month return1.0Point

1m -7.40% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral주주총회소집공고2026-09-01
Neutral기업설명회(IR)개최2026-09-01
Neutral[기재정정]주주총회소집공고2026-09-01
Neutral반기보고서 (2026.06)2026-08-13